HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹757 Cr | ₹662 Cr | ₹828 Cr | ₹703 Cr | ₹653 Cr |
What is the latest Total Current Liabilities ratio of HIKAL ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹757 Cr |
Mar2023 | ₹662 Cr |
Mar2022 | ₹828 Cr |
Mar2021 | ₹703 Cr |
Mar2020 | ₹653 Cr |
How is Total Current Liabilities of HIKAL Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹757 Cr | 14.37 | |
Mar2023 | ₹662 Cr | -20.12 | |
Mar2022 | ₹828 Cr | 17.75 | |
Mar2021 | ₹703 Cr | 7.74 | |
Mar2020 | ₹653 Cr | - |
Compare Total Current Liabilities of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹3,144.8 Cr | -1% | -25.5% | -22.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,187.0 Cr | 0.6% | -2.4% | -7% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,282.0 Cr | -0.3% | -7.6% | 23% | Stock Analytics | |
CIPLA | ₹128,619.0 Cr | 1.8% | 8.1% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,712.0 Cr | 0.9% | 3.7% | 8.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,577.0 Cr | 1% | 2.4% | -9.6% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | -1% |
-25.5% |
-22.6% |
SENSEX | 0.9% |
-1.1% |
0.6% |
You may also like the below Video Courses